Harmony Biosciences Inc. (HRMY)
29.46
0.56 (1.94%)
At close: Apr 24, 2025, 3:59 PM
29.43
-0.10%
After-hours: Apr 24, 2025, 04:20 PM EDT
Company Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States.
Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy.
The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020.
Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
Harmony Biosciences Inc.
| Country | United States |
| IPO Date | Aug 19, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 268 |
| CEO | Dr. Jeffrey M. Dayno M.D. |
Contact Details
Address: 630 West Germantown Pike Plymouth Meeting, Pennsylvania United States | |
| Website | https://www.harmonybiosciences.com |
Stock Details
| Ticker Symbol | HRMY |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001802665 |
| CUSIP Number | 413197104 |
| ISIN Number | US4131971040 |
| Employer ID | 82-2279923 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jeffrey M. Dayno M.D. | President, Chief Executive Officer & Director |
| Adam Zaeske | Executive Vice President & Chief Commercial Officer |
| Andrew Serafin J.D., M.B.A. | Executive Vice President & Chief Strategy Officer |
| Audrey Murphy SPHR | Vice Presidet of Human Resources |
| Brennan Doyle | Vice President & Head of Investor Relations |
| Cate McCanless | Head of Corporate Affairs & Public Policy |
| Christian Ulrich J.D. | General Counsel & Corporate Secretary |
| Dr. Kumar Budur M.D., M.S. | Executive Vice President and Chief Medical & Scientific Officer |
| Jeffrey S. Aronin | Founder & Non-Executive Chairman |
| Tricia Glover | Chief Compliance Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 16, 2025 | 4 | Filing |
| Apr 16, 2025 | 3 | Filing |
| Apr 04, 2025 | 4 | Filing |
| Apr 04, 2025 | 3 | Filing |
| Apr 04, 2025 | ARS | Filing |
| Apr 04, 2025 | DEFA14A | Filing |
| Apr 04, 2025 | DEF 14A | Filing |
| Apr 03, 2025 | 4 | Filing |
| Apr 03, 2025 | 8-K | Current Report |
| Apr 01, 2025 | 4 | Filing |